Dihexa

⚠️ Structural Separation Notice

The Ageless Pep Academy is a clinical education property independent from any commerce operation. Any references in this profile to Ageless Peps product SKUs, pricing, or the agelesspeps.com domain are for completeness and transparency; they are not endorsements and do not form part of the clinical education content. Clinicians are responsible for independent verification of any product sourcing decision. The Academy's Medical Director provides editorial oversight only and does not endorse commercial products.

Quick Facts

• Full Name: Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide)
• Aliases: PNB-0408, HGF enhancer
• Category: Cognitive Enhancement / Neuroprotection / Synaptogenesis
• Type: Oligopeptide / Angiotensin IV analog
• Molecular Weight: ~450 Da
• Administration: Oral / Transdermal
• Typical Dose: 1–10 mg/day
• Half-Life: Long (weeks in CNS tissue); accumulates with use
• Status: Research Only
• WADA Status: Not listed

What It Does

Dihexa is a potent cognitive-enhancing peptide derived from angiotensin IV. It crosses the blood-brain barrier, promotes synaptogenesis (new synapse formation), and dramatically upregulates hepatocyte growth factor (HGF)/c-Met signaling in the brain — a pathway critical for synaptic plasticity and memory. In animal studies, it outperformed BDNF at promoting dendritic spine growth and reversed scopolamine-induced cognitive impairment. Long tissue half-life means it accumulates — use cycles with caution.

Mechanism of Action

1. HGF/c-Met potentiation: Dihexa acts as an HGF enhancer (not a direct agonist) — potentiates endogenous HGF binding to c-Met receptors in the hippocampus and cortex → promotes dendritic branching and synaptogenesis
2. Angiotensin IV / AT4 receptor: Binds IRAP (insulin-regulated aminopeptidase) / AT4 receptor → memory consolidation and synaptic plasticity enhancement
3. BDNF-independent synaptogenesis: Does not require BDNF — complements BDNF pathway
4. BBB penetration: Small, lipophilic molecule that readily crosses the blood-brain barrier; transdermal application also effective
5. Long CNS residency: Weeks-long half-life in neural tissue — effects accumulate; cycles must account for carry-over

Ageless Peps Products

• AP-Dihexa-Vial — Dihexa Vial, $220, retail (draft status)

Dosing Protocols

Standard Protocol

• Dose: 1–10 mg/day oral or transdermal
• Frequency: Once daily
• Duration: 4–8 week cycles; mandatory off-cycles (long tissue accumulation)
• Cycling: 4–8 weeks on, 4–8 weeks off minimum
• Start low: Begin at 1 mg/day to assess tolerance; titrate slowly
• Source: The Peptides Bible, Peptides Made Easy

Transdermal Protocol

• Apply in DMSO carrier or appropriate transdermal base to inner wrist or forearm
• Effective BBB penetration via transdermal route

Stacks Well With

• Semax – synergistic cognitive enhancement (HGF + BDNF pathways)
• Selank – anxiolytic complement to Dihexa's cognitive stimulation
• Noopept – nootropic stack for memory and focus
• NSI-189 – hippocampal neurogenesis complement

Use Cases

• Cognitive Enhancement (memory, learning, focus)
• Neuroprotection (Alzheimer's, neurodegeneration)
• Synaptogenesis (cognitive rehabilitation after TBI, stroke)
• Memory Consolidation
• Age-Related Cognitive Decline

Contraindications & Safety

• Active malignancy — HGF/c-Met signaling promotes cell growth; avoid in cancer
• Long tissue accumulation — DO NOT dose continuously; mandatory cycling
• Limited human data — animal studies only; human safety profile unknown
• Stimulatory effects — anxiety, overstimulation possible at higher doses
• Common side effects: Overstimulation, anxiety, insomnia (if taken late); largely unknown long-term profile

Storage

• Powder/solution: -20°C long-term; 2–8°C short-term
• Transdermal formulation: Follow compounding pharmacy guidance
• Stability: Relatively stable small molecule

PubMed Research

Research links will be added after PubMed search

Sources

• The Peptides Bible – Cognitive peptides section
• Peptide Protocols Master Bible – Nootropic protocols
• McCoy et al., J Pharmacol Exp Ther 2010 — original Dihexa research

#cognitive #neuroprotection #synaptogenesis #nootropic #memory #HGF #peptide #dihexa